Normal view MARC view ISBD view

Phase II trial of hexamethylmelamine in ovarian carcinoma resistant to alkylating agents. [electronic resource]

By:

Bonomi, P D

Contributor(s):

Producer: 19790523Description: 137-8 p. digitalISSN:

0361-5960

Subject(s):

In: Cancer treatment reports vol. 63

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Clinical Trial; Journal Article

There are no comments on this title.

to post a comment.

Previous

Back to results

Next

1
2
3
4
5
6
7
8

1 Knowledge discovery of drug data on the example of adverse reaction prediction.
by Yildirim, Pinar
2 Effects of training about skin cancer on farmers' knowledge level and attitudes.
by Malak, Arzu Tuna
3 Prediction of similarities among rheumatic diseases.
by Yildirim, Pinar
4 Ultrasonographic and clinical evaluation of additional contribution of kinesiotaping to tendon and nerve gliding exercises in the treatment of carpal tunnel syndrome
by Yıldırım, Pınar
5 Mining MEDLINE for the treatment of osteoporosis.
by Yildirim, Pinar
6 Investigation of BRAF mutation analysis with different technical platforms in metastatic melanoma.
by Sener, Ebru
7 Alternative surgical approach for the management of uterine prolapse in young women: preliminary results.
by Karatayli, Rengin
8 Impact of GLP-1 analogue on oxidative damage and hepatic regeneration in experimental 70% hepatectomy model.
by Battal, Muharrem

Close